NAUT NAUTILUS BIOTECHNOLOGY INC

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28, 2022.

Nautilus co-founder and CEO Sujal Patel is scheduled to participate in the following two executive panel discussions:

  • Proteomics “Everything You Wanted to Know, But Were Afraid to Ask” at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
  • CEOs from Spatial Biology/Proteomics at 1:00 p.m. Eastern Time / 10 a.m. Pacific Time

Interested parties may contact to register to attend the virtual event.

About Nautilus Biotechnology, Inc.

With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit .

Media Contact

Investor Contact



EN
23/09/2022

Underlying

NAUTNAUTILUS BIOTECHNOLOGY INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NAUTILUS BIOTECHNOLOGY INC

Jonathan Moreland
  • Jonathan Moreland
Free Trial
PRGO PERRIGO CO. PLC
KURA Kura Oncology ... ... (+10)

InsiderInsights Weekly Report: September 9, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

PRGO PERRIGO CO. PLC
KURA KURA ONCOLOGY INC.
CE CELANESE CORPORATION
ASA ASA
MDU MDU RESOURCES GROUP INC
CECE CECO ENVIRONMENTAL CORP.
NAUT NAUTILUS BIOTECHNOLOGY INC
PFHC PROFRAC HLDG CORP
BPRN BANK OF PRINCETON
SFD SMITHFIELD FOODS INC.
09/10/25 September 10, 2025 1 EN
 PRESS RELEASE
Free
NAUT NAUTILUS BIOTEC...

Nautilus Biotechnology to Participate in Upcoming September Investor C...

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences. Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NYManagement is scheduled to participate in a fireside chat on Monday, September 8h at 10:50 a.m. Pacific Time / 1:50 p.m. Eastern Time. Q3 Investor Summit Group Virtual ConferenceManag...

August 27, 2025 1 EN
 PRESS RELEASE
Free
NAUT NAUTILUS BIOTEC...

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2025. “In Q2, we achieved major milestones that underscore the continued advancement of our platform,” said Sujal Patel, CEO of Nautilus Biotechnology. “Not only did we continue our momentum across both targeted and broadscale proteomic development efforts, but we also publicly share...

July 31, 2025 1 EN
 PRESS RELEASE
Free
NAUT NAUTILUS BIOTEC...

Nautilus Biotechnology Announces Agreement with the Allen Institute, F...

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics • Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience leadership to potentially unlock breakthrough therapeutics and biomarkers for neurodegenerative disease SEATTLE, July 30, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

July 30, 2025 1 EN
 PRESS RELEASE
Free
NAUT NAUTILUS BIOTEC...

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Resul...

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter 2025 before market open on Thursday, July 31, 2025. The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and ...

July 15, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch